Cm-p5, a synthetic antimicrobial peptide shows anti-Trypanosoma cruzi activity.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cm-p5, a synthetic antimicrobial peptide shows anti-Trypanosoma cruzi activity.
- Published In:
- PLoS neglected tropical diseases, 20(3), e0013975 (2026)
- Authors:
- Mengarda, Ana C, Morales-Vicente, Fidel E, Martell-Huguet, Ernesto M, Otero-Gonzalez, Anselmo J, Silber, Ariel M
- Database ID:
- RPEP-15706
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15706APA
Mengarda, Ana C; Morales-Vicente, Fidel E; Martell-Huguet, Ernesto M; Otero-Gonzalez, Anselmo J; Silber, Ariel M. (2026). Cm-p5, a synthetic antimicrobial peptide shows anti-Trypanosoma cruzi activity.. PLoS neglected tropical diseases, 20(3), e0013975. https://doi.org/10.1371/journal.pntd.0013975
MLA
Mengarda, Ana C, et al. "Cm-p5, a synthetic antimicrobial peptide shows anti-Trypanosoma cruzi activity.." PLoS neglected tropical diseases, 2026. https://doi.org/10.1371/journal.pntd.0013975
RethinkPeptides
RethinkPeptides Research Database. "Cm-p5, a synthetic antimicrobial peptide shows anti-Trypanos..." RPEP-15706. Retrieved from https://rethinkpeptides.com/research/mengarda-2026-cmp5-a-synthetic-antimicrobial
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.